<html><body><h2>Case: 732446</h2><h3> CDS Time: 1965-04-21</h3>
<patient name=732446>
65.0 year old Asian_or_Pacific-Islander_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">65</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">UrineProtein_12h</td><td width="200">10</td><td width="200">1961-9-7</td></tr>
<tr><td width="200">Calcium</td><td width="200">10</td><td width="200">1965-4-21</td></tr>
<tr><td width="200">UrineProtein_24h</td><td width="200">10</td><td width="200">1961-9-7</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">80</td><td width="200">1965-4-14</td></tr>
<tr><td width="200">Glucose</td><td width="200">230</td><td width="200">1962-2-24</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">4</td><td width="200">1965-4-1</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">251</td><td width="200">1965-3-16</td></tr>
<tr><td width="200">Chloride</td><td width="200">107.0</td><td width="200">1965-4-21</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">42</td><td width="200">1965-3-16</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">78</td><td width="200">1965-4-13</td></tr>
<tr><td width="200">B 12</td><td width="200">983.0</td><td width="200">1963-4-4</td></tr>
<tr><td width="200">Weight</td><td width="200">222</td><td width="200">1965-4-13</td></tr>
<tr><td width="200">HbA1C</td><td width="200">9</td><td width="200">1965-4-14</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">121</td><td width="200">1965-3-16</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">317</td><td width="200">1965-3-16</td></tr>
<tr><td width="200">SGOT</td><td width="200">38</td><td width="200">1965-4-14</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">133</td><td width="200">1965-4-13</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1965-4-14</td></tr>
<tr><td width="200">Height</td><td width="200">67</td><td width="200">1965-4-13</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1965-4-21</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">317</td><td width="200">1965-3-16</td></tr>
<tr><td width="200">BUN</td><td width="200">27</td><td width="200">1965-4-21</td></tr>
<tr><td width="200">HCT</td><td width="200">35</td><td width="200">1965-4-21</td></tr>
<tr><td width="200">HGB</td><td width="200">12</td><td width="200">1965-4-21</td></tr>
<tr><td width="200">Sodium</td><td width="200">138</td><td width="200">1965-4-21</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1965-4-14</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.0</td><td width="200">1965-4-21</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">9</td><td width="200">1965-4-14</td></tr>
<tr><td width="200">UrineProtein_Qualitative</td><td width="200">10.0</td><td width="200">1961-9-7</td></tr>
<tr><td width="200">UrineProtein_Spot</td><td width="200">10</td><td width="200">1961-9-7</td></tr>
<tr><td width="200">Pulse</td><td width="200">72</td><td width="200">1965-4-13</td></tr>
<tr><td width="200">PLT</td><td width="200">182</td><td width="200">1965-4-21</td></tr>
<tr><td width="200">WBC</td><td width="200">8</td><td width="200">1965-4-21</td></tr>
<tr><td width="200">eGFR</td><td width="200">44</td><td width="200">1962-10-30</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1965-4-20</td></tr>
<tr><td width="200">SGPT</td><td width="200">32</td><td width="200">1965-4-14</td></tr>
<tr><td width="200">Race</td><td width="200">Asian_or_Pacific-Islander_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Disorders Lipid Metabolism</td><td width="200"></td><td width="200">1965-3-16</td></tr>
<tr><td width="200">Coronary_Artery_Disease</td><td width="200"></td><td width="200">1965-4-21</td></tr>
<tr><td width="200">CVA</td><td width="200"></td><td width="200">1964-8-8</td></tr>
<tr><td width="200">Occulusion of cerebral arteries</td><td width="200"></td><td width="200">1965-4-21</td></tr>
<tr><td width="200">nausea</td><td width="200"></td><td width="200">1964-7-17</td></tr>
<tr><td width="200">Hyperlipidemia</td><td width="200"></td><td width="200">1965-3-16</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1965-4-20</td></tr>
<tr><td width="200">Myocardial_Infarction</td><td width="200"></td><td width="200">1965-4-21</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1965-3-30</td></tr>
<tr><td width="200">Renal disease</td><td width="200"></td><td width="200">1965-4-20</td></tr>
<tr><td width="200">Renal_Insufficiency</td><td width="200"></td><td width="200">1965-4-20</td></tr>
<tr><td width="200">Transient cerebral ischemia</td><td width="200"></td><td width="200">1965-3-14</td></tr>
</table>
<p><b>Medications:</b> aspirin(81.0) glyburide(20.0) losartan(100.0) simvastatin(80.0) atenolol(25.0) lisinopril(20.0) lovastatin(40.0) enalapril(40.0) Insulin(24.0) pioglitazone(15.0) clonidine(0.4) labetalol(100.0) metformin(1000.0) atorvastatin(80.0) hydralazine(30.0) hydrochlorothiazide(25.0) sitagliptin(50.0) glipizide(20.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> hyperglycemia[Glucose(230.0/1962-2-24)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of myocardial infarction]()</td></tr>
<tr><td width="200">Dyslipidemia Lab criteria</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab criteria[LDL_Cholesterol(251.0/1965-3-16)]()</td></tr>
<tr><td width="200">DM (2ary prev)  BP controlled</td>
<td width="200"></td>
<td width="200"> Diabetes (Secondary Prevention)[Treatment_Diastolic_BP(78/null) && Treatment_Systolic_BP(133/null) && presence of diabetes mellitus]()</td></tr>
<tr><td width="200">MI (secondary prevention) BP controlled</td>
<td width="200"></td>
<td width="200"> Myocardial Infarction (Secondary Prevention)[Treatment_Diastolic_BP(78/null) && Treatment_Systolic_BP(133/null) && presence of myocardial infarction]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(65.0/1970-1-1)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of dyslipidemia lab criteria]()</td></tr>
<tr><td width="200">CKD by eGFR</td>
<td width="200"></td>
<td width="200"> CKD by eGFR[eGFR(44.0/1962-10-30)]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[eGFR(44.0/1962-10-30)]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Hypertension with MI and K>=3.5</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.1/1965-4-21) && presence of MI]()</td></tr>
<tr><td width="200">drug intolerance ACE/ARB OR hypotension OR renal insufficiency</td>
<td width="200"></td>
<td width="200"> drug intolerance ACE/ARB OR hypotension OR renal insufficiency[presence of renal insufficiency ICD9]()</td></tr>
<tr><td width="200">MI no HF</td>
<td width="200"></td>
<td width="200"> MI no HF[Absence of HF && Presence of MI]()</td></tr>
<tr><td width="200">Acitve prescription for ACE and ARB</td>
<td width="200"></td>
<td width="200"> Acitve prescription for ACE and ARB[ACE I being used && Presence of ARB]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">High Risk for HF and DM, HTN, or atherosclerotic vascular disease</td>
<td width="200"></td>
<td width="200"> High Risk for HF and DM, HTN, or atherosclerotic vascular disease[diabetes_mellitus && Absence of HF]()</td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1965-04-20</td>
<td width="200"> Renal_Insufficiency()</td></tr>
<tr> <td width="200"></td>
<td width="200">1965-04-20</td>
<td width="200"> Renal disease()</td></tr>
<tr><td width="200">CCS-7.4</td>
<td width="200">1965-03-14</td>
<td width="200"> Transient cerebral ischemia()</td></tr>
<tr> <td width="200"></td>
<td width="200">1965-04-21</td>
<td width="200"> Occulusion of cerebral arteries()</td></tr>
<tr> <td width="200"></td>
<td width="200">1964-08-08</td>
<td width="200"> CVA()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1965-04-21</td>
<td width="200"> Myocardial_Infarction()</td></tr>
<tr> <td width="200"></td>
<td width="200">1965-04-21</td>
<td width="200"> Coronary_Artery_Disease()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1965-03-30</td>
<td width="200"> Hypertension()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.1/1965-4-21) && presence of MI]()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1965-03-16</td>
<td width="200"> Disorders Lipid Metabolism()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1965-04-20</td>
<td width="200"> DM-Type2()</td></tr>
<tr><td width="200">Hypertension_Defined</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.1/1965-4-21) && presence of MI]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1965-03-16</td>
<td width="200"> Hyperlipidemia()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1964-07-17</td>
<td width="200"> nausea()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage B HF
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> SBP < 140 and DBP < 80(presence of diabetes mellitus)
<p><b>Reached goal?</b> achieved(Treatment_Diastolic_BP(78/null) && Treatment_Systolic_BP(133/null))
<p>
<b>Goal:</b> LDL< 100 mg/dL(CHD Risk Equivalent)
<p><b>Reached goal?</b> failed(LDL_Cholesterol(251.0/1965-3-16))
<p><b>Messages by Types</b>
<ul>
<li><b>Class I</b>
<ul>
<li>In patients at high risk for developing HF, lipid disorders should
be treated in accordance with contemporary guidelines. (Level of
Evidence: A)
<li>Patients at high risk for developing HF should be counseled to avoid behaviors that may increase the risk of HF (e.g., smoking, excessive alcohol consumption, and illicit drug use). (Level of
Evidence: C)
<li>Healthcare providers should perform periodic evaluation for signs
and symptoms of HF in patients at high risk for developing HF.
(Level of Evidence: C)
<li>For patients with diabetes mellitus (who are all at high risk for developing HF), blood sugar should be controlled in accordance with contemporary guidelines. (Level of Evidence: C)
<li>Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
<li>Patients who have not developed HF symptoms should be treated according to contemporary guidelines after an acute MI. (Level of Evidence: C).
</ul>
<li><b>Class III</b>
<ul>
<li>Routine use of nutritional supplements solely to prevent the development of structural heart disease should not be recommended for patients at high risk for developing HF. (Level of
Evidence: C)
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage A messages</b><br>
<ul>
<li><b>Lipid disorder control <font color=FF0000>preferred</font></b>(rule in criterion<i> Lipid not under control</i> evaluate to <b> true</b> because <i>Lipid not under controlLDL_Cholesterol(251.0/1965-3-16)</i>)])
In patients at high risk for developing HF, lipid disorders should
be treated in accordance with contemporary guidelines. (Level of
Evidence: A)
<li><b>behavior control <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Patients at high risk for developing HF should be counseled to avoid behaviors that may increase the risk of HF (e.g., smoking, excessive alcohol consumption, and illicit drug use). (Level of
Evidence: C)
<li><b>Periodic evaluation <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Healthcare providers should perform periodic evaluation for signs
and symptoms of HF in patients at high risk for developing HF.
(Level of Evidence: C)
<li><b>Blood sugar control <font color=FF0000>preferred</font></b>(rule in criterion<i> diabetes_mellitus</i> evaluate to <b> true</b> because <i>diabetes_mellitus</i>)])
For patients with diabetes mellitus (who are all at high risk for developing HF), blood sugar should be controlled in accordance with contemporary guidelines. (Level of Evidence: C)
<li><b>not use nutritional supplements <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Routine use of nutritional supplements solely to prevent the development of structural heart disease should not be recommended for patients at high risk for developing HF. (Level of
Evidence: C)
</ul>
<li><b>Secondary prevention</b><br>
<ul>
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
Patients who have not developed HF symptoms should be treated according to contemporary guidelines after an acute MI. (Level of Evidence: C).
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>digoxin<ul><li>preference: neutral<li>No comment</ul><li>Ace_Inhibitor(Captopril, Lisinopril)<ul><li>Already being used<li><font color=FF0000>Compelling indications:  Myocardial_Infarction(Myocardial_Infarction) </font><li>Relative indications:  High Risk for HF and DM, HTN, or atherosclerotic vascular disease(High Risk for HF and DM, HTN, or atherosclerotic vascular disease[diabetes_mellitus && Absence of HF]) <li>preference: ruled out</ul><li>Beta blocker stage B post MI(Carvedilol)<ul><li>Already being used<li><font color=FF0000>Compelling indications:  MI no HF(MI no HF[Absence of HF && Presence of MI]) </font><li>preference: ruled out</ul><li>ARB<ul><li>Already being used<li>Relative indications:  High Risk for HF and DM, HTN, or atherosclerotic vascular disease(High Risk for HF and DM, HTN, or atherosclerotic vascular disease[diabetes_mellitus && Absence of HF]) <li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Myocardial_Infarction(Myocardial_Infarction) <li>preference: ruled out</ul><li>Beta Blocker Stage B no MI<ul><li>Already being used<li>preference: ruled out</ul></ul></body></html>